Herold Advisors Inc. Acquires 333 Shares of CVS Health Co. (NYSE:CVS)

Herold Advisors Inc. grew its holdings in CVS Health Co. (NYSE:CVS) by 1.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 23,965 shares of the pharmacy operator’s stock after purchasing an additional 333 shares during the quarter. Herold Advisors Inc.’s holdings in CVS Health were worth $1,893,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of CVS. FMR LLC boosted its stake in CVS Health by 29.1% during the 3rd quarter. FMR LLC now owns 27,487,238 shares of the pharmacy operator’s stock worth $1,919,159,000 after acquiring an additional 6,194,441 shares during the last quarter. International Assets Investment Management LLC raised its holdings in CVS Health by 8,697.2% during the 4th quarter. International Assets Investment Management LLC now owns 1,322,129 shares of the pharmacy operator’s stock worth $104,395,000 after buying an additional 1,307,100 shares during the period. Canada Pension Plan Investment Board raised its holdings in shares of CVS Health by 49.9% in the third quarter. Canada Pension Plan Investment Board now owns 2,095,978 shares of the pharmacy operator’s stock valued at $146,341,000 after purchasing an additional 698,054 shares during the last quarter. Pacer Advisors Inc. raised its holdings in shares of CVS Health by 12.6% in the fourth quarter. Pacer Advisors Inc. now owns 5,513,230 shares of the pharmacy operator’s stock valued at $435,325,000 after purchasing an additional 616,785 shares during the last quarter. Finally, J.P. Morgan Private Wealth Advisors LLC acquired a new stake in shares of CVS Health in the third quarter valued at approximately $34,379,000. Institutional investors own 80.66% of the company’s stock.

Insider Activity

In other news, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the transaction, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.24% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of analysts have recently issued reports on CVS shares. Royal Bank of Canada lowered their price objective on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a report on Thursday, February 8th. Leerink Partnrs reissued an “outperform” rating on shares of CVS Health in a research note on Monday, February 26th. StockNews.com cut shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. Barclays began coverage on shares of CVS Health in a research report on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price objective for the company. Finally, Wells Fargo & Company reduced their target price on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating for the company in a research report on Monday, April 8th. Four analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $89.44.

CVS Health Stock Down 0.2 %

Shares of NYSE CVS opened at $67.18 on Friday. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The company has a market cap of $84.68 billion, a price-to-earnings ratio of 10.40, a PEG ratio of 0.89 and a beta of 0.52. CVS Health Co. has a 12 month low of $64.41 and a 12 month high of $83.25. The stock has a 50-day moving average price of $74.42 and a two-hundred day moving average price of $73.64.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping the consensus estimate of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The firm had revenue of $93.81 billion during the quarter, compared to the consensus estimate of $90.58 billion. During the same quarter in the previous year, the firm earned $1.99 earnings per share. The business’s quarterly revenue was up 11.9% on a year-over-year basis. As a group, analysts forecast that CVS Health Co. will post 8.31 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.96%. The ex-dividend date of this dividend is Friday, April 19th. CVS Health’s dividend payout ratio is currently 41.18%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.